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Abstract
We surveyed infectious disease specialists about early coronavirus disease 2019 (COVID-19) vaccination preparedness. Almost all responding
institutions rated their facility’s preparedness plan as either excellent or adequate. Vaccine hesitancy and concern about adverse reactions were
the most commonly anticipated barriers to COVID-19 vaccination. Only 60% believed that COVID-19 vaccination should be mandatory.
(Received 17 February 2021; accepted 12 April 2021; electronically published 19 April 2021)

The initially limited supplies of vaccines against coronavirus disease
2019 (COVID-19) prompted the prioritization of high-risk groups.
Healthcare personnel (HCP) were included because they are at risk
of exposure, are critical to maintaining healthcare delivery systems,
and because, if infected, they may infect their patients with COVID19. Although vaccinating HCP is an important approach to preventing the spread of vaccine-preventable illnesses in healthcare settings,1,2 vaccination rates for some diseases are suboptimal.3
Given the morbidity and mortality associated with COVID-19, as
well as its ability to spread in healthcare settings, low vaccination
rates among HCP would pose a serious concern for public health.
Multiple challenges confront current campaigns to vaccinate HCP
against COVID-19: addressing vaccine hesitancy, communicating
about and managing potential side effects, scheduling multiple doses,
prioritizing different groups of HCP, and unpredictable supply requiring staged rollouts of the vaccination. There are also logistical issues
related to vaccine storage and handling. Infectious disease physicians
may play an important role in informing this vaccination process, and
they are likely to be asked questions about COVID-19 vaccination by
their colleagues. The purpose of this survey was to learn more about
plans to vaccinate HCP against COVID-19.
Methods
A 10-question, web-based survey link was distributed to all 1,837
active infectious disease (ID) physician members of the Infectious
Diseases Society of America (IDSA) Emerging Infections Network
(EIN). The IDSA EIN is funded by the CDC to serve as a provider-based surveillance network for emerging infections and related
phenomena.4 The survey was open between December 10, 2020, and
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January 2, 2021. Nonresponding members were sent e-mail reminders twice after the initial e-mail. An opt-out answer option was provided for members who were not aware of COVID-19 vaccination
plans at their hospital or institution. Respondents were not required
to answer all questions, so total responses to individual questions varied. The survey asked about vaccine prioritization in the member’s
healthcare institution, how the initial planned vaccination process
was structured, barriers to HCP vaccination, and longer-term vaccination management strategies. Members’ practice characteristics were
obtained from the EIN member database. Categorical variables were
compared using the χ2 test or the Fisher exact test and SAS version 9.4
software (SAS Institute, Cary, NC).
Results
In total, 767 ID physicians responded among 1,837 active members
(42%). Moreover, 178 respondents (23% of 767 respondents)
indicated that they were not aware of COVID-19 vaccine plans;
30 of these respondents answered 1 of the survey questions, and
589 respondents answered most of the survey questions. The total
possible denominator for each question was 619.
Practice characteristics of the 767 respondents are shown in
Table 1. Respondents were significantly more likely than nonrespondents to have >14 years of ID experience (P < .0001). All US
Census divisions are represented, as are a variety of hospital types;
22% of respondents represented community hospitals.
Vaccine prioritization
In total, 571 respondents (95%) reported that their facilities had a plan
for determining which HCP would be vaccinated first. Among a list of
possible prioritization methods, respondents could select any that
applied. The most frequent choice was ‘by hospital unit,’ which
was indicated by 226 (40%). An additional 254 respondents selected
‘by hospital unit’ along with other option(s), resulting in 480 of 571
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Table 1. Practice Characteristics of Survey Responders
Characteristic

Table 2. Barriers to HCP Vaccination as Reported by 566 Infectious Disease
Physiciansa
No. (%)
Barrier

Practice type
Adult infectious diseases

591 (77)

Pediatric infectious diseases

176 (23)

Region
New England

67 (9)

Mid Atlantic

109(14)

East North Central

103 (13)

West North Central

76 (10)

South Atlantic

129 (17)

East South Central

38 (5)

West South Central

57 (7)

Mountain

39 (5)

Pacific

142 (19)

Puerto Rico or Canada
Years experience since ID fellowship

No. (%)

Willingness of HCP to receive vaccine (hesitancy)

326 (58)

Concern about adverse reactions (eg, allergic reaction)

318 (56)

Staff absences related to anticipated side effects such as fever

263 (46)

Sufficient occupational health staff to manage vaccination

214 (38)

Priority selection of first staff to receive vaccine

176 (31)

Cold storage requirement for vaccine

100 (18)

Physical space to vaccinate while maintaining social distancing

98 (17)

Recordkeeping/vaccination reporting to public health

90 (16)

Difficulty getting to vaccine administration location(s) for HCP

65 (11)

Other

0 (0)

Note. HCP, healthcare personnel.
a
Respondents were asked to select the top 4 barriers to COVID-19 vaccine rollout in their
facilities. Numbers add to >100%.

7 (1)
a

<5 y

137 (18)

5–14 y

241 (31)

15–24 y

165 (21)

≥25 y

224 (29)

Employment
Hospital/clinic

274 (36)

Private/group practice

160 (21)

University/medical school

297 (39)

VA and military

36 (5)

Primary hospital type

whereas 227 (38%) of 599 said yes but only when there are sufficient supplies or when the prioritization scheme reaches them.
Regarding workplace absences for expected vaccine side effects
(eg, fever, myalgias, headache), 354 (59%) reported that their
facility had a plan to manage postvaccination symptoms (eg, to
differentiate COVID-19 from postvaccine symptoms and to determine which HCP need work restrictions), and 380 (63%) reported
that their facility planned to stagger vaccinations within units
to avoid staff shortages. Also, 588 rated their facility’s current
preparedness for rapid vaccine rollout. The responses were as
follows: ‘excellent’ (n = 278, 47%), ‘adequate’ (n = 285, 49%),
and ‘not ready’ (n = 25, 4%).
Barriers to HCP vaccination

Community

166 (22)

Nonuniversity teaching

206 (27)

University

319 (42)

VA hospital or Department of Defense

40 (5)

City/county (public)

31 (4)

Note. ID, infectious disease; VA, Veterans’ Affairs.
a
Respondents were significantly more likely than nonrespondents to have >14 years of ID
experience (P < .0001).

Respondents were asked to select the top 4 barriers to COVID-19
vaccine rollout in their facilities, among 10 listed options (Table 2).
Among 566 respondents, the single option selected most often was
“willingness of HCP to receive vaccine (ie, hesitancy),” which was
indicated by 326 (58%). There were 180 different combinations of
responses, and the most frequent was “hesitancy” plus “staff
absences” plus “adverse reactions” by 35 (6%).
Long-term vaccine management strategies

(84%) who reported that hospital unit or area (eg, COVID wards,
ICUs) would be the primary prioritization method. Other prioritization methods included by job title or type of work (n = 182, 32%),
HCP at highest risk of severe illness due to age or comorbidities
(n = 175, 31%), lottery (n = 24, 4%), first come–first served (n = 20,
4%), other (n = 19, 3%), and not sure (n = 16, 3%).
Respondents were asked about 4 possible exclusion criteria.
HCP who had documented COVID-19 any time in 2020 were
the least likely to be offered vaccine in the initial rollout (n = 370,
61%), followed by HCP who had documented COVID-19 in the
last 90 days (n = 218, 36%), pregnant or lactating HCP (n = 224,
37%), and HCP with a history of anaphylaxis (n = 147, 25%).
Initial vaccination process
Only 73 (12%) of 599 respondents reported that their facilities
planned to publicly vaccinate senior leadership as soon as possible,
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Respondents were asked whether influenza and COVID-19
(after full FDA approval) vaccinations should be mandatory with
medical exemptions for HCP. Moreover, 90% believed that influenza vaccination should be mandatory, whereas only 60% believed
that COVID-19 vaccination should be mandatory. Finally, when
asked how concerned they were about the potential for vaccine
refusal or hesitancy among HCP in their own facility, 25% reported
being very concerned, 63% reported being somewhat concerned,
and 12% reported no concern.
Discussion
Our results demonstrate that almost all respondents’ institutions
had a plan for vaccination in place prior to vaccine release,
and most of these respondents rated their facility’s preparedness
for a rapid vaccine rollout as either excellent or adequate.
Vaccine hesitancy was the most commonly anticipated barrier
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to COVID-19 vaccination, and concern about adverse reactions
was the second most common barrier. Only 60% believed that
COVID-19 vaccination should be mandatory.
Vaccine hesitancy is associated with vaccine-preventable
disease outbreaks5,6 and, for COVID-19, may add to the risk of
increasing the spread of SARs-CoV-2. Indeed, our respondents
listed vaccine hesitancy as the greatest threat to COVID-19 vaccination campaigns. Interestingly, whereas 90% were in favor of
mandatory influenza vaccination for HCP, only 60% were in favor
of mandatory COVID-19 vaccination. For influenza, making the
vaccine mandatory for HCP has been a highly effective approach
to increasing vaccination rates.7,8 As the COVID-19 vaccination
campaign proceeds, experience with available vaccines grows,
and vaccine supply increases, opinions about making it mandatory
may shift. Other approaches to improving vaccine uptake include
using community leaders to reinforce the value of vaccination to
protect the community and to correct misinformation.9,10
Our study has several limitations. Approximately 20% of US ID
physicians are EIN members, and they must elect to join. Thus,
these results may not be fully generalizable. We collected ID
physician opinions; responses were not validated by data collected
from institutions. Finally, physicians who were involved in developing COVID-19 vaccination plans may have been more likely to
respond and rate those plans as adequate.
Despite the limitations, our results indicate that most
healthcare institutions appear to have adequate plans for COVID-19
vaccination, but respondents expressed concerns about vaccine hesitancy and the risk of side effects as barriers to vaccination. Our results
highlight the need to monitor HCP vaccination rates and possible
barriers.
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